BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35695648)

  • 1. Effects of Allocryptopine on the Proliferation and Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma through m6A Mediated Hedgehog Signaling Pathway.
    Gong J; Wang C; Zhang F; Lan W
    J Environ Pathol Toxicol Oncol; 2022; 41(2):15-24. PubMed ID: 35695648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
    Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
    PeerJ; 2022; 10():e12991. PubMed ID: 35223210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 6. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
    Xu T; Zhang W; Chai L; Liu C; Zhang S; Xu T
    Oral Dis; 2023 Mar; 29(2):639-648. PubMed ID: 34479400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m
    Luo R; Xie L; Lin Y; Shao J; Lin Z
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
    Lu X; Wang Z; Huang H; Wang H
    J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1.
    Wen Z; Zhang Y; Gao B; Chen X
    J Gene Med; 2024 Feb; 26(2):e3669. PubMed ID: 38380717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
    Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
    Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
    Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
    J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMA3 Promotes Tumorigenesis of Oral Squamous Cell Carcinoma by METTL3-Mediated N6-Methyladenosine Modification.
    Ning B; Mei Y
    Crit Rev Immunol; 2024; 44(2):49-59. PubMed ID: 38305336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.
    Liu H; Xu X; Wu R; Bi L; Zhang C; Chen H; Yang Y
    Biomed Res Int; 2021; 2021():6616547. PubMed ID: 34212035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.